Stockreport

SEC fines Clovis Oncology Inc., executives $20.8 million for lying about cancer drug effectiveness [MarketWatch]

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF SEC fines Clovis Oncology Inc., executives $20.8 million for lying about cancer drug effectiveness Clovis Oncology Inc., CLVS, +0.03% will pay $20 million to settle c [Read more]